RE:A patent update Pertinent comments from the PDF file (Sorry copy & paste is/was not available for the PDF file)
Reasons for Allowance:
The following is an examiner's statement of reasons for allowance:
Claims 1-3 and 5-21 of the instant application claim a method for treating cancer comprising administering at least one cannabinoid receptor agonist, administering a photodynamic compound and administering radiation to the subject in whom the at least one cannabinoid receptor agonist and the photodynamic compound are present so as to activate the photodynamic compound to generate at least one of radicals and reactive oxygen species to destroy the cancer cells to treat the cancer, wherein the photodynamic compound is further combined with a metal binding glycoprotein such as transferrin.
The Application demonstrates that the addition of a cannabinoid receptor agonist to photodynamic therapy (radiation and a photodynamic compound) produces synergy as shown in the declaration under 37 CFR 1.132 filed on August 26, 2021.
Since the "prior art" does not specifically teach the combination of a cannabinoid receptor agonist, a photodynamic compound and moreover since Applicant has discovered that the combination produces synergy in the treatment of cancer
cells which could not have been predicted in view of the cited prior art, the claims of the instant application are novel, and non-obvious in view of the closest related prior art.